» Articles » PMID: 36246566

Mechanisms of Xiaochaihu Decoction on Treating Hepatic Fibrosis Explored by Network Pharmacology

Overview
Journal Dis Markers
Publisher Wiley
Specialty Biochemistry
Date 2022 Oct 17
PMID 36246566
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To explore the material basis and pharmacological mechanism of Xiaochaihu Decoction (XCHD), the classic Traditional Chinese Medicine (TCM) formula in inhibiting hepatic fibrosis (HF).

Methods: The main components in XCHD were screened from the TCMSP database, ETCM database, and literature, and their potential targets were detected and predicted using the Swiss Target Prediction platform. The HF-related targets were retrieved and screened through GeneCard database and OMIM database, combined with GEO gene chips. The XCHD targets and HF targets were mapped to search common targets. The protein-protein interaction (PPI) network was acquired via the STRING11.0 database and analyzed visually using Cytoscape 3.8.0 software. The potential mechanisms of the common targets identified through GO and KEGG pathway enrichment analysis were analyzed by using Metascape database. The results were visualized through OmicShare Tools. The "XCHD compound-HF target" network was visually constructed by Cytoscape 3.8.0 software. AutoDockVina1.1.2 and PyMoL software were used to verify the molecular docking of XCHD main active compounds and HF key targets.

Results: A total of 164 potential active compounds from XCHD were screened to act on 95 HF-related targets. Bioinformatics analysis revealed that quercetin, -sitosterol, and kaempferol may be candidate agents, which acted on multiple targets like PTGS2, HSP90AA1, and PTGS1 and regulate multiple key biological pathways like IL-17 signaling pathway, TNF signaling pathway and PI3K-Akt signaling pathway to relieve HF. Moreover, molecular docking suggested that quercetin and PTGS2 could statically bind and interact with each other through amino acid residues val-349, LEU-352, PHE-381, etc.

Conclusion: This work provides a systems perspective to study the relationship between Chinese medicines and diseases. The therapeutic efficacy of XCHD on HF was the sum of multitarget and multi-approach effects from the bioactive ingredients. This study could be one of the cornerstones for further research.

Citing Articles

Chinese medicine in the treatment of chronic hepatitis B: The mechanisms of signal pathway regulation.

Zheng S, Qi W, Xue T, Zao X, Xie J, Zhang P Heliyon. 2024; 10(20):e39176.

PMID: 39640799 PMC: 11620126. DOI: 10.1016/j.heliyon.2024.e39176.


Liver Extracellular Vesicles and Particles Enriched β-Sitosterol Effectively Promote Liver Regeneration in Mice.

Gongye X, Xia P, Ma T, Chai Y, Chen Z, Zhu Y Int J Nanomedicine. 2024; 19:8117-8137.

PMID: 39139504 PMC: 11319097. DOI: 10.2147/IJN.S465346.


Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine.

Zheng S, Xue C, Li S, Zao X, Li X, Liu Q Front Pharmacol. 2024; 15:1381476.

PMID: 39081955 PMC: 11286405. DOI: 10.3389/fphar.2024.1381476.


Uncovering the molecular mechanism of Mume Fructus in treatment of Sjögren's syndrome.

Sun Z, Deng L, Xu Z, Yang K, Yu P Medicine (Baltimore). 2024; 103(19):e38085.

PMID: 38728503 PMC: 11081559. DOI: 10.1097/MD.0000000000038085.


Screening for MicroRNA combination with engineered exosomes as a new tool against osteosarcoma in elderly patients.

Han J, Zhao Z, Wang Y, Yu T, Wan D Front Bioeng Biotechnol. 2022; 10:1052252.

PMID: 36545680 PMC: 9760984. DOI: 10.3389/fbioe.2022.1052252.

References
1.
Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S . The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. Curr Protoc Bioinformatics. 2016; 54:1.30.1-1.30.33. DOI: 10.1002/cpbi.5. View

2.
Elmowafy E, El-Derany M, Biondo F, Tiboni M, Casettari L, Soliman M . Quercetin Loaded Monolaurate Sugar Esters-Based Niosomes: Sustained Release and Mutual Antioxidant-Hepatoprotective Interplay. Pharmaceutics. 2020; 12(2). PMC: 7076437. DOI: 10.3390/pharmaceutics12020143. View

3.
Pinzi L, Rastelli G . Molecular Docking: Shifting Paradigms in Drug Discovery. Int J Mol Sci. 2019; 20(18). PMC: 6769923. DOI: 10.3390/ijms20184331. View

4.
Xu F, Liu C, Zhou D, Zhang L . TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis. J Histochem Cytochem. 2016; 64(3):157-67. PMC: 4810800. DOI: 10.1369/0022155415627681. View

5.
Zhang S, Cui N, Zhuo Y, Li D, Liu J . Modified Xiaochaihu Decoction () prevents the progression of chronic pancreatitis in rats possibly by inhibiting transforming growth factor-β1/Sma- and mad-related proteins signaling pathway. Chin J Integr Med. 2013; 19(12):935-9. DOI: 10.1007/s11655-013-1656-7. View